WCN25-3225 APOLIPOPROTIEN E IN C3 GLOMERULOPATHAY-A VALIDATION

WCN25-3225 APOLIPOPROTIEN E IN C3 GLOMERULOPATHAY-A VALIDATION

Saved in:

Bibliographic Details
Main Authors:	Ritambhra Nada DUSEJA, ASHWANI KUMAR, RAJA RAMACHANDRAN
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924026962
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4582 COLLAPSING GLOMERULOPATHY- MICROSCOPY ON AUTOPSY TISSUE AN ENRICHING EXPERIENCE
by: Ritambhra Nada DUSEJA, et al.
Published: (2025-02-01)

Serum and urine apolipoprotien A1 (ApoA1) as biomarkers in bladder cancer
by: Farhan Hussien Khalaf, et al.
Published: (2024-06-01)

WCN25-4036 Improved Outcomes with an Additional Rituximab Dose in Primary Membranous Nephropathy
by: Vinod Kumar, et al.
Published: (2025-02-01)

WCN25-4122 Rituximab in Primary Membranous Nephropathy- three years outcome
by: Prabjot Kaur Johal, et al.
Published: (2025-02-01)

WCN24-1513 ELEVATED MBL LEVELS AND ITS ASSOCIATION WITH ENDOTHELIAL DYSFUNCTION IN PMN
by: DEEKSHA PAL, et al.
Published: (2024-04-01)

WCN25-3507 RISK FACTORS PREDICTING INFECTIONS IN POST KIDNEY TRANSPLANT RECIPIENTS
by: Raja Ramachandran, et al.
Published: (2025-02-01)

Horoscopes Prepared by Master Astrologers from Krakow at the Turn of the 15th and 16th Century (according to the BJ 3225 and 3227 manuscripts)
by: Sylwia Konarska-Zimnicka
Published: (2016-11-01)

WCN25-1613 GLUCOCORTICOID TOXICITY INDEX IN MEMBRANOUS NEPHROPATHY AND PODOCYTOPATHIES IN ADULT: A PILOT STUDY
by: RAJESH KUMAR, et al.
Published: (2025-02-01)

WCN25-4072 Podocyte Dysfunction Triggered by miR193a: The Role of P-Bodies
by: Vinod Kumar, et al.
Published: (2025-02-01)

WCN25-4408 Clinical Outcomes of FSGS with Nephrotic Syndrome at 1-Year: Findings from the ITANGIBLE Registry
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN25-809 NOT YOUR TYPICAL MGUS
by: Sreedhar Mandayam, et al.
Published: (2025-02-01)

WCN25-2675 C3 GLOMERULOPATHY RARE DISEASE AND NEW THERAPUTIC APPROACH
by: Emad Khater, et al.
Published: (2025-02-01)

WCN25-2963 Clinical profile and treatment responses in C3 Glomerulonephritis: A case series
by: Pinki Kumari, et al.
Published: (2025-02-01)

WCN25-4132 IL-31 and JAK-STAT Signaling in CKD-aP: Exploring Therapeutic Implication
by: Mohinder Kaur, et al.
Published: (2025-02-01)

WCN25-3918 C3GN ASSOCIATED WITH DELETIONS IN CHFR1 AND CHFR3 GENES
by: PARUL AHLAWAT, et al.
Published: (2025-02-01)

WCN25-3835 WHICH GFR FORMULA IS MOST ACCURATE IN INDIAN CIRRHOTIC POPULATION?
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN25-4086 Peripheral distribution of Immature, Mature and NET forming Neutrophils in CKD-Associated Pruritus: Novel Insight into Disease Pathogenesis
by: Prabhjot Kaur Johal, et al.
Published: (2025-02-01)

WCN25-2701 UNRAVELLING THE INFLUENCE OF CYP3A5 GENOTYPE AND C0/D RATIO ON RENAL TRANSPLANT OUTCOMES: A RETROSPECTIVE ANALYSIS
by: Prathiba Parthasarathy, et al.
Published: (2025-02-01)

WCN25-4466 Baseline parameters of IgA Nephropathy Using the Oxford MEST Score: Insights from the I-TANGIBLE Registry
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN25-1081 STUDY OF CLINICAL SIGNIFICANCE OF IgM AND C3 GLOMERULAR DEPOSITIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
by: Prajit mazumdar, et al.
Published: (2025-02-01)

IgA Nephropathy and IgA Vasculitis Post-COVID-19 vaccination: A case-based review
by: Arun Prabhahar, et al.
Published: (2022-04-01)

WCN25-2664 Low-dose versus Standard-dose cyclical Cyclophosphamide and Steroids in the treatment of Primary Membranous Nephropathy- a randomized controlled trial
by: Raja Ramachandran, et al.
Published: (2025-02-01)

WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
by: Carla Nester, et al.
Published: (2025-02-01)

WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING
by: Meghana Rao C, et al.
Published: (2025-02-01)

WCN25-3674 MYRIAD PRESENTATIONS OF AN UNCOMMON DISEASE
by: SALONI AGARWAL, et al.
Published: (2025-02-01)

Bortezomib-based Chemotherapy and Bone-marrow Followed by Renal Transplantation in Multiple Myeloma: A Literature Review
by: Jasmine Sethi, et al.
Published: (2025-04-01)

WCN25-1280 TREATMENT WITH VITAMIN C AND THIAMINE IN PATIENTS WITH SEPSIS AND RENAL FAILURE
by: Kumaresan Ramanathan, et al.
Published: (2025-02-01)

WCN25-2572 C3 GLOMERULONEPHRITIS – A RARE CAUSE OF ACUTE GLOMERULONEPHRITIS IN A YOUNG MALE WITH HBH DISEASE
by: YASWANTH KILAPARTHI, et al.
Published: (2025-02-01)

WCN25-1237 C3 GLOMERULONEPHRITIS: UNIQUE PRESENTATION AND ROLE OF GENETIC TESTING - NEW WINE IN A NEW BOTTLE
by: Sankar Niranjan, et al.
Published: (2025-02-01)

WCN25-1789 A DIAGNOSTIC CHALLENGE CASE REPORT: C3-GLOMERULONEPHRITIS IN A 17-YEAR-OLD ADOLESCENT
by: Olga Serebryakova, et al.
Published: (2025-02-01)

WCN25-4235 CHRONICITY SCORE AND NOT MEST C SCORE IS A BETTER PREDICTOR OF PROGNOSIS IN IGA NEPHROPATHY
by: TULSI MODI, et al.
Published: (2025-02-01)

WCN25-4233 THE FITNESS PARADOX
by: Swetha rajkumar, et al.
Published: (2025-02-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN25-2811 LONG TERM DISEASE REMISSION IN A CASE OF RAPIDLY PROGRESSIVE RENAL FAILURE DUE TO C3 GLOMERULONEPHRITIS
by: Girish Kumthekar, et al.
Published: (2025-02-01)

WCN25-2829 CLINICAL SPECTRUM OF LUPUS NEPHRITIS IN CHILDREN
by: Ashish kumar Das, et al.
Published: (2025-02-01)

WCN25-4114 PERITONEAL DIALYSIS IN NEPAL – MOTIVATIONS AND BARRIERS
by: Nabin Basnet, et al.
Published: (2025-02-01)

WCN25-4460 UTILITY OF ANTI HLA ANTIBODIES ASSESSED BY SINGLE ANTIGEN BEAD ASSAY TO PREDICT EARLY GRAFT DYSFUNCTION IN PATIENTS UNDERGOING KIDNEY TRANSPLANT
by: Rajat Grover, et al.
Published: (2025-02-01)

WCN25-4090 The Diagnostic potential of Serum Gd-IgA1 to C3 ratio in IgA nephropathy: A single center prospective study
by: Ravi tej Madipalli, et al.
Published: (2025-02-01)

WCN25-2919 Clinical Profile and Impact of Immunosuppressants in Patients with C3GN: A Retrospective Analysis in a North Indian Cohort
by: Vinay Sagar, et al.
Published: (2025-02-01)

WCN25-4316 CLINICAL PROFILE AND TREATMENT OUTCOMES OF IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND C3 GLOMERULONEPHRITIS IN A TERTIARY CARE CENTER
by: Tonmay Barai, et al.
Published: (2025-02-01)